Canon U.S.A. Announces Strategic Investment in Spartan Bioscience
March 18 2015 - 9:58AM
Business Wire
Canon BioMedical, Inc. to help support the
R&D of future diagnostic products
Canon U.S.A., Inc., a leader in digital imaging solutions, today
announced that it has made a strategic investment in Spartan
Bioscience Inc., a leader in on-demand DNA testing, to help fund
the research and development of new diagnostic testing products.
Canon BioMedical, Inc., the recently established wholly- owned
subsidiary of Canon U.S.A., Inc., plans to explore areas to work
with Spartan on the development of future diagnostic products,
including rapid genetic testing.
“Canon is excited to work with Spartan Bioscience Inc., on
developing breakthrough technologies in the area of genetic
testing,” said Seymour Liebman, executive vice president, chief
administrative officer and general counsel, Canon U.S.A., Inc.
“Spartan’s goals align with our mission to provide enhanced
diagnostic testing systems that can help improve human health
worldwide.”
“We are excited to continue our efforts as we move into new
markets for rapid genetic testing,” said Paul Lem, M.D., CEO of
Spartan Bioscience Inc. “Working with Canon will help accelerate
our progress in the future.”
Seymour Liebman, member of the Board of Directors of Canon
BioMedical, Inc., will join the Board of Directors of Spartan
Bioscience.
About Canon BioMedical, Inc.
Canon BioMedical, Inc. is focused on empowering the biomedical
research and healthcare communities by developing, manufacturing
and marketing innovative technologies and solutions. The
technologies and solutions developed will help enable clinicians
and scientists to improve our health and advance science. Canon
BioMedical will continue to pursue innovative solutions in line
with Canon’s Kyosei philosophy through the use of existing and
emerging Canon technology, as well as strategic partnerships.
About Canon U.S.A., Inc.
Canon U.S.A., Inc., is a leading provider of consumer,
business-to-business, and industrial digital imaging solutions to
the United States and to Latin America and the Caribbean (excluding
Mexico) markets. With approximately $31 billion in global revenue,
its parent company, Canon Inc. (NYSE:CAJ), ranked third overall in
U.S. patents granted in 2014† and is one of Fortune Magazine's
World’s Most Admired Companies in 2015. In 2014, Canon U.S.A.
received the PCMag.com Readers’ Choice Award for Service and
Reliability in the digital camera and printer categories for the
11th consecutive year. Canon U.S.A. is committed to the highest
level of customer satisfaction and loyalty, providing 100 percent
U.S.-based consumer service and support for all of the products it
distributes. Canon U.S.A. is dedicated to its Kyosei philosophy of
social and environmental responsibility. In 2014, the Canon
Americas Headquarters secured LEED® Gold certification, a
recognition for the design, construction, operations and
maintenance of high-performance green buildings. To keep apprised
of the latest news from Canon U.S.A., sign up for the Company's RSS
news feed by visiting www.usa.canon.com/rss and follow us on
Twitter @CanonUSA.
About Spartan Bioscience Inc.
Spartan Bioscience Inc. is the leader in on-demand DNA testing.¹
Spartan is bringing complete sample-to-result DNA testing systems
to medicine. Spartan’s technology fully integrates DNA collection,
extraction, and analysis, with an intuitive interface that is easy
to operate. For the first time, healthcare providers and their
patients can get DNA results on demand. For more information,
please visit our website at: http://www.spartanbio.com.
† Based on weekly patent counts issued by United States Patent
and Trademark Office.
All referenced product names, and other marks, are trademarks of
their respective owners.
¹ Roberts JD et al. (2012). Lancet. 379:1705–11.
Canon U.S.A. website:http://www.usa.canon.comFor sales
information/customer support:1-800-OK-CANONorEditorial:Canon U.S.A., Inc.Emily Moran,
631-330-2403emmoran@cusa.canon.com
Canon (NYSE:CAJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Canon (NYSE:CAJ)
Historical Stock Chart
From Apr 2023 to Apr 2024